Progeria
Diagnostyka i diagnoza

Progeria, znana również jako zespół Hutchinsona-Gilforda (HGPS), to rzadkie schorzenie genetyczne charakteryzujące się przyspieszonym starzeniem u dzieci, spowodowane mutacją w genie LMNA, najczęściej heterozygotyczną mutacją c.1824C>T (p.Gly608Gly) w eksonie 11. Diagnostyka opiera się na charakterystycznych objawach klinicznych, takich jak zahamowanie wzrostu (poniżej pediatrycznej krzywej centylowej), utrata włosów, utrata tkanki tłuszczowej podskórnej, mikrognacja, nieprawidłowości stawów biodrowych oraz specyficzne cechy twarzy, a także na potwierdzeniu mutacji w badaniu genetycznym DNA z krwi. W diagnostyce uzupełniającej stosuje się badania laboratoryjne (lipidy, insulinooporność, morfologia), obrazowe (RTG kości, MRI, echokardiografia, DEXA) oraz ocenę histologiczną skóry. W diagnostyce różnicowej należy wykluczyć inne zespoły progerioidalne i lipodystrofie. Wczesne rozpoznanie umożliwia wdrożenie leczenia, w tym stosowanie lonafarnibu (Zokinvy) u dzieci powyżej 12 miesięcy i powierzchni ciała ≥0,39 m², co może wydłużyć życie o około 2,5 roku oraz spowolnić progresję choroby.

Progeria – Diagnostyka

Progeria (zespół Hutchinsona-Gilforda, HGPS) jest niezwykle rzadkim schorzeniem genetycznym, charakteryzującym się przyspieszonym procesem starzenia u dzieci. Rozpoznanie tej choroby opiera się na charakterystycznych objawach klinicznych oraz badaniach genetycznych potwierdzających mutację w genie LMNA, która prowadzi do produkcji nieprawidłowego białka – progeryny. Wczesna diagnostyka umożliwia wdrożenie leczenia i zapewnienie lepszej jakości życia pacjentom.12

Rozpoznanie kliniczne

Podejrzenie progerii zazwyczaj pojawia się w pierwszym lub drugim roku życia, kiedy stają się widoczne charakterystyczne cechy przedwczesnego starzenia. Rozpoznanie kliniczne opiera się na obserwacji specyficznych objawów fizycznych, które obejmują:34

  • Zahamowanie wzrostu (spadek poniżej pediatrycznej krzywej wzrostu)
  • Utratę włosów (łysienie)
  • Utratę podskórnej tkanki tłuszczowej
  • Opóźnione i niepełne wyrzynanie się zębów mlecznych
  • Cofnięcie żuchwy (mikrognacja)
  • Nieprawidłowości stawów biodrowych
  • Napięcie lub uwypuklenie skóry w okolicy brzucha lub ud
  • Charakterystyczne cechy twarzy
  • 56

Podczas badania fizykalnego lekarz przeprowadza szczegółową ocenę stanu dziecka, która obejmuje:7

  • Pomiar wzrostu i masy ciała
  • Naniesienie pomiarów na siatki centylowe
  • Badanie słuchu i wzroku
  • Pomiar parametrów życiowych, w tym ciśnienia tętniczego
  • Ocenę widocznych objawów progerii
  • 89

Diagnostyka genetyczna

Potwierdzenie rozpoznania progerii wymaga przeprowadzenia badań genetycznych. Od czasu odkrycia genu odpowiedzialnego za progerię w 2003 roku, możliwe jest wykonanie specyficznego testu diagnostycznego.10

Badanie genetyczne polega na analizie DNA pobranego z próbki krwi pacjenta w celu wykrycia mutacji w genie LMNA. W klasycznej postaci HGPS najczęściej występuje heterozygotyczna mutacja c.1824C>T (p.Gly608Gly) w eksonie 11 genu LMNA.1112

W nieklasycznej postaci HGPS rozpoznanie ustala się u pacjenta z objawami sugerującymi HGPS i heterozygotyczną mutacją w genie LMNA, która albo optymalizuje kryptyczny donor splicingowy eksonu 11, albo deoptymalizuje donor splicingowy intronu 11.13

Podejścia w zakresie badań genetycznych mogą obejmować:14

Fundacja Badań nad Progerią (The Progeria Research Foundation) oferuje program diagnostyczny we współpracy z laboratorium zatwierdzonym przez CLIA (Clinical Laboratory Improvement Amendments), który umożliwia wykonanie badań genetycznych dla dzieci z podejrzeniem zespołu Hutchinsona-Gilforda. Wyniki testu genetycznego zwykle są dostępne w ciągu 2-4 tygodni.1617

Badania uzupełniające

W diagnostyce progerii oraz w celu monitorowania postępu choroby stosuje się również szereg badań dodatkowych:18

Nowsze badania wykazały, że podwyższone poziomy kwasu hialuronowego mogą być wykrywane w moczu pacjentów z progerią, co może stanowić dodatkowy marker diagnostyczny.21

Diagnostyka różnicowa

W procesie diagnostycznym progerii ważne jest wykluczenie innych schorzeń o podobnych objawach klinicznych, takich jak:22

  • Atypowe zespoły progerioidalne
  • Dermatopatia restrykcyjna
  • Rodzinna częściowa lipodystrofia (FPLD)
  • Zespół Wiedemanna-Rautenstraucha
  • Wrodzona uogólniona lipodystrofia
  • Zespół Cockayne’a
  • Dysplazja żuchwowo-obojczykowa
  • Zespół progerioidalny Petty’ego-Laxovej-Wiedemanna
  • 2324

Warto zaznaczyć, że przed odkryciem testu genetycznego błędne diagnozy były częste. Obecnie, dzięki możliwości diagnostyki molekularnej, rozpoznanie jest bardziej precyzyjne i może być postawione na wcześniejszym etapie rozwoju choroby.2526

Znaczenie wczesnej diagnostyki

Wczesna diagnoza progerii ma kluczowe znaczenie z kilku powodów:27

  • Umożliwia wczesne rozpoczęcie leczenia, w tym zastosowanie lonafarnib (Zokinvy), który może spowalniać postęp choroby i wydłużyć życie o około 2,5 roku
  • Pozwala na regularne monitorowanie powikłań sercowo-naczyniowych, które są główną przyczyną zgonów
  • Daje możliwość wdrożenia odpowiedniej opieki medycznej i poprawy jakości życia
  • Umożliwia poradnictwo genetyczne dla rodziców, informując ich o ryzyku wystąpienia progerii u kolejnych dzieci
  • 2829

Należy podkreślić, że mutacja genetyczna powodująca progerię rzadko jest dziedziczona w rodzinach. W większości przypadków zmiana genowa, która wywołuje progerię, pojawia się przypadkowo. Badanie genetyczne w kierunku zespołu Hutchinsona-Gilforda służy również do uspokojenia rodziców chorych dzieci, że ich schorzenie wynika ze sporadycznej mutacji genetycznej i dlatego mało prawdopodobne jest, aby przyszłe potomstwo miało ten stan.3031

Opieka po diagnozie

Po postawieniu diagnozy progerii, dziecko powinno być objęte kompleksową opieką multidyscyplinarną, która obejmuje:32

  • Regularne monitorowanie wzrostu i rozwoju
  • Okresowe badania kardiologiczne (EKG, echokardiografia)
  • Badania obrazowe (RTG, MRI)
  • Badania stomatologiczne, okulistyczne i audiologiczne
  • Konsultacje z genetykiem klinicznym
  • Ocenę parametrów metabolicznych (lipidy, glukoza)
  • 3334

Leczenie progerii, choć nie jest leczeniem przyczynowym, może obejmować:35

Należy zaznaczyć, że leczenie lonafarnibem można rozpocząć, gdy pacjent ma co najmniej 12 miesięcy i powierzchnię ciała (BSA) 0,39 m² lub większą.38 W niektórych przypadkach, jak pokazuje przykład z Izraela, dzieci są diagnozowane wcześniej (nawet w wieku 2 miesięcy), ale leczenie lonafarnibem rozpoczyna się dopiero po ukończeniu pierwszego roku życia.39

Wyzwania diagnostyczne

Pomimo postępów w diagnostyce progerii, wciąż istnieją pewne wyzwania:40

  • Średni czas do postawienia diagnozy wynosi około 4 lat, a w 20% przypadków zajmuje 10 lat lub więcej
  • Ze względu na rzadkość występowania (szacuje się na 1 na 4-8 milionów żywych urodzeń), wielu lekarzy może nie mieć doświadczenia w rozpoznawaniu tej choroby
  • Ograniczone badania i finansowanie w tej dziedzinie utrudniają rozwój nowych metod diagnostycznych i terapeutycznych
  • Niektóre atypowe formy progerii mogą przedstawiać trudności diagnostyczne
  • 4142

W przypadku podejrzenia progerii ważne jest, aby skierować pacjenta do specjalistów z doświadczeniem w tej dziedzinie lub skontaktować się z Fundacją Badań nad Progerią, która może zapewnić dostęp do testów diagnostycznych i najnowszych informacji dotyczących leczenia.43

Postępy w diagnostyce

Najnowsze badania w dziedzinie diagnostyki progerii koncentrują się na:44

  • Definiowaniu „fenomu progerii” – zestawu cech fenotypowych związanych z progerią, co może ułatwić diagnozę pacjentów i identyfikację nowych zespołów progerioidalnych
  • Rozwoju narzędzi do oceny prawdopodobieństwa, że dany zespół lub pacjent ma charakter progerioidalny
  • Badaniach nad nowymi markerami biologicznymi, które mogłyby ułatwić wczesną diagnozę
  • Rozwoju technik obrazowania, które mogą pomóc w identyfikacji wczesnych zmian związanych z progerią
  • 45

Warto również zaznaczyć, że prowadzone są badania nad nowymi terapiami, które w połączeniu z lonafarnibem mogłyby dalej zwiększyć zarówno oczekiwaną długość życia, jak i jakość życia chorych dzieci.46

Podsumowanie diagnostyki progerii

Diagnoza progerii opiera się na kombinacji oceny klinicznej i badań genetycznych. Charakterystyczne objawy fizyczne, takie jak zahamowanie wzrostu, utrata włosów i specyficzne cechy twarzy, zazwyczaj stają się widoczne w pierwszym lub drugim roku życia, co prowadzi do klinicznego podejrzenia choroby. Potwierdzenie diagnozy wymaga wykonania badania genetycznego w celu identyfikacji mutacji w genie LMNA.47

Wczesna diagnostyka jest kluczowa dla optymalnego zarządzania chorobą i poprawy jakości życia pacjentów. Po postawieniu diagnozy, dzieci z progerią powinny być objęte kompleksową opieką multidyscyplinarną, z regularnym monitorowaniem pod kątem powikłań sercowo-naczyniowych oraz innych problemów zdrowotnych związanych z chorobą.48

Pomimo postępów w diagnostyce i leczeniu, progeria pozostaje rzadką, nieuleczalną chorobą. Jednakże, dzięki zwiększonej świadomości, dostępności testów genetycznych i rozwojowi nowych terapii, pacjenci z progerią mogą obecnie uzyskać lepszą opiekę i potencjalnie dłuższe życie niż w przeszłości.49

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Diagnostic Testing | The Progeria Research Foundation
    https://www.progeriaresearch.org/the-prf-diagnostic-testing-program/
    The Progeria Research Foundation, in association with a CLIA-approved diagnostics lab, is pleased to provide a DNA-based, diagnostic test for children suspected of having Hutchinson-Gilford Progeria Syndrome (HGPS). […] With the gene finding, it is now possible to provide a scientific test to definitively diagnose children with Progeria. […] Scientists now know that HGPS is usually caused by a change of only one letter in the billions of letters that make up the human genome (DNA). That change can be seen using genetic sequencing, in which the gene is decoded and its sequence is determined letter by letter. […] Now PRF has a genetic test that can identify HGPS. This can translate into earlier diagnosis, fewer misdiagnoses and early medical intervention to ensure a better quality of life for the children.
  • #2 Hutchinson-Gilford Progeria Syndrome – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1121/
    Hutchinson-Gilford progeria syndrome (HGPS) is characterized in the first year of life by growth deficiency, lagophthalmos, hair loss, delayed and incomplete primary tooth eruption, subcutaneous fat loss, and areas of abnormal skin (tightness, stippling, and/or small outpouchings over the abdomen and upper thighs). […] The diagnosis of classic or nonclassic genotype HGPS is established in a proband with characteristic clinical features and a heterozygous pathogenic variant in LMNA that results in production of progerin, the disease-causing abnormal lamin A protein, identified by molecular genetic testing. […] The clinical diagnosis of Hutchinson-Gilford progeria syndrome (HGPS) can be established in a proband when characteristic pathognomonic features emerge. Molecular testing should accompany a clinical diagnosis (see Establishing the Diagnosis).
  • #3 Progeria – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/progeria/diagnosis-treatment/drc-20356043
    Health care providers may suspect progeria based on symptoms. A genetic test for changes in the LMNA gene can confirm the diagnosis of progeria. […] A thorough physical exam of your child includes: Measuring height and weight. Putting measurements on a growth curve chart. Testing hearing and vision. Measuring vital signs, including blood pressure. Looking for visible symptoms of progeria. […] Progeria is a very rare condition. Your health care provider may need to gather more information before deciding on the next steps in caring for your child. Discussion of your questions and concerns will be helpful.
  • #4 Progeria – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/progeria/symptoms-causes/syc-20356038
    Progeria is usually found in infancy or early childhood. This often happens at regular checkups, when a baby first shows the distinctive signs of premature aging. […] If you notice changes in your child that could be symptoms of progeria, or you have any concerns about your child’s growth or development, make an appointment with your child’s health care provider. […] There’s no cure for progeria, but new treatments and research show some promise for managing symptoms and complications. […] A change in one gene causes progeria. This gene, known as lamin A (LMNA), makes a protein that’s needed to hold the center of a cell, called the nucleus, together. […] The changed gene that causes progeria is rarely passed down in families. In most cases, the rare gene change that causes progeria happens by chance.
  • #5 Progeria (Hutchinson-Gilford Progeria Syndrome) | Boston Children’s Hospital
    https://www.childrenshospital.org/conditions/progeria
    Genetic testing can confirm HGPS when physical signs suggest progeria. Early signs include tightness or bulging of the skin in the abdominal or thigh area, failure to thrive (falling well below the pediatric growth curve), a lack of body fat, a receding chin, abnormalities of the hip joints, and delayed or incomplete teething. […] Genetic testing can be done through a geneticist or is available at no cost to families through the Progeria Research Foundation. Results typically are returned in two to four weeks.
  • #6 Hutchinson-Gilford Progeria Syndrome – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1121/
    Hutchinson-Gilford progeria syndrome (HGPS) is characterized in the first year of life by growth deficiency, lagophthalmos, hair loss, delayed and incomplete primary tooth eruption, subcutaneous fat loss, and areas of abnormal skin (tightness, stippling, and/or small outpouchings over the abdomen and upper thighs). […] The diagnosis of classic or nonclassic genotype HGPS is established in a proband with characteristic clinical features and a heterozygous pathogenic variant in LMNA that results in production of progerin, the disease-causing abnormal lamin A protein, identified by molecular genetic testing. […] The clinical diagnosis of Hutchinson-Gilford progeria syndrome (HGPS) can be established in a proband when characteristic pathognomonic features emerge. Molecular testing should accompany a clinical diagnosis (see Establishing the Diagnosis).
  • #7 Progeria – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/progeria/diagnosis-treatment/drc-20356043
    Health care providers may suspect progeria based on symptoms. A genetic test for changes in the LMNA gene can confirm the diagnosis of progeria. […] A thorough physical exam of your child includes: Measuring height and weight. Putting measurements on a growth curve chart. Testing hearing and vision. Measuring vital signs, including blood pressure. Looking for visible symptoms of progeria. […] Progeria is a very rare condition. Your health care provider may need to gather more information before deciding on the next steps in caring for your child. Discussion of your questions and concerns will be helpful.
  • #8 Progeria | UM Health-Sparrow
    https://www.uofmhealthsparrow.org/departments-conditions/conditions/progeria
    Health care providers may suspect progeria based on symptoms. A genetic test for changes in the LMNA gene can confirm the diagnosis of progeria. […] A thorough physical exam of your child includes: Measuring height and weight. Putting measurements on a growth curve chart. Testing hearing and vision. Measuring vital signs, including blood pressure. Looking for visible symptoms of progeria.
  • #9 Hutchinson-Gilford Progeria Syndrome: Causes, Symptoms, Risk Factors, Diagnosis and Treatment
    https://www.prepladder.com/neet-pg-study-material/pediatrics/hutchinson-gilford-progeria-syndrome-causes-symptoms-risk-factors-diagnosis-and-treatment
    Medical experts could suspect progeria based on the patient’s symptoms. Progeria can be diagnosed with certainty using a genetic test that looks for changes in the LMNA gene. […] A thorough physical examination of your child includes: Weight and height measurements. Calculating and displaying a growth curve. Examining the ears and eyes. Measuring the blood pressure and other vital indicators. Looking for signs of progeria externalis.
  • #10 Diagnostic Testing | The Progeria Research Foundation
    https://www.progeriaresearch.org/the-prf-diagnostic-testing-program/
    The Progeria Research Foundation, in association with a CLIA-approved diagnostics lab, is pleased to provide a DNA-based, diagnostic test for children suspected of having Hutchinson-Gilford Progeria Syndrome (HGPS). […] With the gene finding, it is now possible to provide a scientific test to definitively diagnose children with Progeria. […] Scientists now know that HGPS is usually caused by a change of only one letter in the billions of letters that make up the human genome (DNA). That change can be seen using genetic sequencing, in which the gene is decoded and its sequence is determined letter by letter. […] Now PRF has a genetic test that can identify HGPS. This can translate into earlier diagnosis, fewer misdiagnoses and early medical intervention to ensure a better quality of life for the children.
  • #11 Hutchinson-Gilford Progeria Syndrome – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1121/
    The diagnosis of classic genotype HGPS is established in a proband suggestive findings and a heterozygous c.1824CT pathogenic variant in LMNA identified by molecular genetic testing (see Table 1). […] The diagnosis of nonclassic genotype HGPS is established in a proband with suggestive findings similar to classic genotype HGPS and a heterozygous progerin-producing pathogenic variant that either optimizes a cryptic exon 11 splice donor site or deoptimizes the intron 11 splice donor site of LMNA identified by molecular genetic testing (see Table 1). […] Molecular genetic testing approaches can include a combination of gene-targeted testing (single gene testing, multigene panel) and comprehensive genomic testing (exome sequencing, genome sequencing).
  • #12 The clinical characteristics of Asian patients with classical-type Hutchinson–Gilford progeria syndrome | Journal of Human Genetics
    https://www.nature.com/articles/jhg201790
    HutchinsonGilford progeria syndrome (HGPS) is an extremely rare genetic disorder that shows a characteristic progeria phenotype. […] In conclusion, to circumvent or minimalize severe vascular complication, an early diagnosis, careful observation and, promisingly, new intervention with farnesylation inhibitors may improve the prognosis of classical HGPS patients. […] Both phenotype and genetic confirmation of a LMNA mutation are essential for the diagnosis of HGPS; classic type is defined based on the recognition of common clinical features and the presence of the c.1824CT (p.Gly608Gly) heterozygous pathogenic variant in the LMNA gene. […] The genetic examination of the LMNA gene is essential for the diagnosis of classical or other types of progeria; thus, the LMNA gene should be analyzed with careful consideration in children who display the characteristic phenotypes and in whom HGPS is suspected.
  • #13 Hutchinson-Gilford Progeria Syndrome – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1121/
    The diagnosis of classic genotype HGPS is established in a proband suggestive findings and a heterozygous c.1824CT pathogenic variant in LMNA identified by molecular genetic testing (see Table 1). […] The diagnosis of nonclassic genotype HGPS is established in a proband with suggestive findings similar to classic genotype HGPS and a heterozygous progerin-producing pathogenic variant that either optimizes a cryptic exon 11 splice donor site or deoptimizes the intron 11 splice donor site of LMNA identified by molecular genetic testing (see Table 1). […] Molecular genetic testing approaches can include a combination of gene-targeted testing (single gene testing, multigene panel) and comprehensive genomic testing (exome sequencing, genome sequencing).
  • #14 Hutchinson-Gilford Progeria Syndrome – GeneReviews® – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK1121/
    The diagnosis of classic genotype HGPS is established in a proband suggestive findings and a heterozygous c.1824CT pathogenic variant in LMNA identified by molecular genetic testing (see Table 1). […] The diagnosis of nonclassic genotype HGPS is established in a proband with suggestive findings similar to classic genotype HGPS and a heterozygous progerin-producing pathogenic variant that either optimizes a cryptic exon 11 splice donor site or deoptimizes the intron 11 splice donor site of LMNA identified by molecular genetic testing (see Table 1). […] Molecular genetic testing approaches can include a combination of gene-targeted testing (single gene testing, multigene panel) and comprehensive genomic testing (exome sequencing, genome sequencing).
  • #15 Genetic testing for – Blueprint Genetics
    https://blueprintgenetics.com/tests/panels/dermatology/progeria-and-progeroid-syndromes-panel/
    Is ideal for patients with a clinical suspicion of Hutchinson-Gilford progeria syndrome or a syndrome with progeroid features. […] Diagnosis is based on clinical features and detection of heterozygous LMNA variants either within exon 11 (termed classic HGPS) or at the intronic border of exon 11 (termed atypical HGPS). […] Although no other gene than LMNA associates with HGPS, premature aging occur in many other syndromes with so-called progeroid features, thus the panel also include genes causing the following syndromes: Cockayne syndrome, congenital generalized lipodystrophy, cutis laxa and progeroid type Ehlers-Danlos syndrome among some others. […] The performance metrics listed below are from an initial validation performed at our main laboratory in Finland. The performance metrics of our laboratory in Marlborough, MA, are equivalent. […] Our interpretation team analyzes millions of variants from thousands of individuals with rare diseases.
  • #16 Progeria (Hutchinson-Gilford Progeria Syndrome) | Boston Children’s Hospital
    https://www.childrenshospital.org/conditions/progeria
    Genetic testing can confirm HGPS when physical signs suggest progeria. Early signs include tightness or bulging of the skin in the abdominal or thigh area, failure to thrive (falling well below the pediatric growth curve), a lack of body fat, a receding chin, abnormalities of the hip joints, and delayed or incomplete teething. […] Genetic testing can be done through a geneticist or is available at no cost to families through the Progeria Research Foundation. Results typically are returned in two to four weeks.
  • #17 Progeria and processing-deficient Progeroid Laminopathies | Sentynl Therapeutics, Inc.
    https://www.zokinvy.com/hcp/understanding-progeria-and-pdpl
    Early diagnosis of Progeria and PDPL allows for earlier, targeted intervention. […] Once a diagnosis is confirmed, initiate Zokinvy immediately if the patient is 12 months of age or older and with a body surface area (BSA) of 0.39 m2 and above. […] Genetic testing to detect LMNA or ZMPSTE24 mutations is offered by labs. […] The Progeria Research Foundation offers a genetic testing program through laboratories certified by Certified Laboratory Improvement Amendments (CLIA) and in collaboration with the treating physician.
  • #18 Progeria: Sign, Symptoms & Risk Factors | HGPS Causes & Treatment
    https://www.delveinsight.com/blog/progeria-causes-symptoms-risk-factors-and-treatment-options
    How is Progeria diagnosed? HGPS is usually diagnosed during the first or second year of life when progeroid features begin to appear visibly. The diagnosis is based on examining physical characteristics such as height and weight, facial appearance, stiffness of joints, hearing and vision testing, and many others. Progeria is misdiagnosed with another disease with similar characteristics. The analysis of patient history, specialized imaging tests, and genetic testing for LMNA mutations confirm progerias diagnosis. […] Progeria is not curable; however, the treatment option eases or delays some of the signs and symptoms. Specific therapies for individuals with HGPS are symptomatic and supportive. Medication, changes in diet lifestyle, and physical occupational therapy are the most common treatment options. The treatments also depend on the childs condition and symptoms.
  • #19 The first case report of a child with progeria syndrome in Oman | ESPE2023 | 61st Annual ESPE (ESPE 2023) | ESPE Abstracts
    https://abstracts.eurospe.org/hrp/0097/hrp0097p2-71
    Hutchison-Gilford progeria syndrome (HGPS) is a rare genetic disorder which is characterized by aging fast in affected individuals. […] The patient was evaluated by multidisciplinary team for the various problems. […] Genetic testing by (PCR) with western blot protein analysis can confirm the diagnosis. […] Multidiscipline workup, including ECG, echocardiogram, carotid duplex scanning, hip Xdash;rays and bone densitometry scans should be done annually. […] Till now, no cure has been found for this catastrophic disorder however Lonafarnib is recently approved by FDA as the as the first treatment of progeria.
  • #20 Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model | Immunity & Ageing | Full Text
    https://immunityageing.biomedcentral.com/articles/10.1186/1742-4933-6-4
    Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder that belongs to a group of conditions called laminopathies which affect nuclear lamins. […] The aim of this work was to compile a comprehensive literature review of the clinical features and genetic mutations and mechanisms of this syndrome as a contribution to health care workers. […] This review shows the necessity of a more detailed clinical identification of Hutchinson-Gilford progeria syndrome and the need for more studies on the pharmacologic and pharmacogenomic approach to this syndrome. […] The diagnostic methods of HGPS are clinical (serum lipid levels, hyaluronic acid excretion, blood count), histological (biopsies from areas of abdominal skin with abnormal nuclear morphology), radiological (abnormality found in the brain, thorax, long bones and phalanges) and by screening for mutations in the gene LMNA.
  • #21 Progeria – Diagnosis
    https://www.medindia.net/health/conditions/progeria-diagnosis.htm
    There are no specific tests to diagnose progeria. Identifying the disease often depends on inferences made from the physical appearance of the child within the first two years of birth, when changes begin to appear. […] Genetic testing may also be carried out to detect mutations in the Lamin A gene in a progeria patient. […] Recent research has revealed that elevated levels of hyaluronic acid can be detected in the urine of Progeria patients.
  • #22 Progeria differential diagnosis – wikidoc
    https://www.wikidoc.org/index.php/Progeria_differential_diagnosis
    Hutchinson-Gilford progeria syndrome (HGPS) must be differentiated from other diseases such as Atypical progeria syndromes, Restrictive dermopathy, Familial partial lipodystrophy (FPLD), Wiedemann-Rautenstrauch syndrome, Congenital generalized lipodystrophy, Cockayne syndrome, Mandibuloacral dysplasia and Petty-Laxova-Wiedemann progeroid syndrome. […] Hutchinson-Gilford progeria syndrome (HGPS) must be differentiated from the following: Atypical progeria syndromes, Restrictive dermopathy, Familial partial lipodystrophy (FPLD), Wiedemann-Rautenstrauch syndrome, Congenital generalized lipodystrophy, Cockayne syndrome, Mandibuloacral dysplasia, Petty-Laxova-Wiedemann progeroid syndrome.
  • #23 Progeria differential diagnosis – wikidoc
    https://www.wikidoc.org/index.php/Progeria_differential_diagnosis
    Hutchinson-Gilford progeria syndrome (HGPS) must be differentiated from other diseases such as Atypical progeria syndromes, Restrictive dermopathy, Familial partial lipodystrophy (FPLD), Wiedemann-Rautenstrauch syndrome, Congenital generalized lipodystrophy, Cockayne syndrome, Mandibuloacral dysplasia and Petty-Laxova-Wiedemann progeroid syndrome. […] Hutchinson-Gilford progeria syndrome (HGPS) must be differentiated from the following: Atypical progeria syndromes, Restrictive dermopathy, Familial partial lipodystrophy (FPLD), Wiedemann-Rautenstrauch syndrome, Congenital generalized lipodystrophy, Cockayne syndrome, Mandibuloacral dysplasia, Petty-Laxova-Wiedemann progeroid syndrome.
  • #24 Progeria – Pediatrics – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pediatrics/miscellaneous-disorders-in-infants-and-children/progeria
    Progeria is a rare syndrome of accelerated aging that manifests early in childhood and causes premature death. […] Diagnosis of progeria is usually obvious by appearance but must be distinguished from segmental progerias (eg, acrogeria, metageria) and other causes of growth failure.
  • #25 Progeria – Wikipedia
    https://en.wikipedia.org/wiki/Progeria
    Skin changes, abnormal growth, and loss of hair occur. These symptoms normally start appearing by one year of age. A genetic test for LMNA mutations can confirm the diagnosis of progeria. […] Prior to the advent of the genetic test, misdiagnosis was common.
  • #26 About Progeria
    https://www.genome.gov/Genetic-Disorders/Progeria
    Progeria is an extremely rare genetic disease of childhood characterized by dramatic, premature aging. […] A genetic test for Hutchinson-Gilford progeria syndrome, also called HGPS, is currently available. In the past, doctors had to base a diagnosis of progeria solely on physical symptoms, such as skin changes and a failure to gain weight, that were not fully apparent until a child’s first or second year of life. This genetic test now enables doctors to diagnose a child at a younger age and initiate treatment early in the disease process. […] This genetic test for Hutchinson-Gilford progeria syndrome also serves to reassure parents of affected children that their disorder stems from a sporadic genetic mutation and that therefore it is unlikely that any future offspring would have the condition.
  • #27 Progeria and processing-deficient Progeroid Laminopathies | Sentynl Therapeutics, Inc.
    https://www.zokinvy.com/hcp/understanding-progeria-and-pdpl
    Early diagnosis of Progeria and PDPL allows for earlier, targeted intervention. […] Once a diagnosis is confirmed, initiate Zokinvy immediately if the patient is 12 months of age or older and with a body surface area (BSA) of 0.39 m2 and above. […] Genetic testing to detect LMNA or ZMPSTE24 mutations is offered by labs. […] The Progeria Research Foundation offers a genetic testing program through laboratories certified by Certified Laboratory Improvement Amendments (CLIA) and in collaboration with the treating physician.
  • #28 Progeria (Hutchinson-Gilford Progeria Syndrome — HGPS): Symptoms & Causes
    https://my.clevelandclinic.org/health/diseases/17850-progeria
    Progeria is a rare genetic condition that causes rapid aging in children. […] A drug called lonafarnib may slow down the progression of the disease. […] If they suspect progeria, they can use genetic testing to confirm the diagnosis. The test requires taking a blood sample from your child. […] Progeria treatment includes the use of a drug called lonafarnib (Zokinvy). […] Treatment with the drug lonafarnib has shown promising results and has extended the life of people with progeria by two-and-a-half years.
  • #29 LMNA Gene Hutchinson-Gilford progeria NGS Genetic Test Cost 20000 INR in India
    https://dnalabsindia.com/test/lmna-gene-hutchinson-gilford-progeria-ngs-genetic-dna-test
    NGS Genetic Test detects for variant and mutation detection in LMNA gene for Hutchinson-Gilford progeria […] The diagnosis of Hutchinson-Gilford Progeria Syndrome is based on the physical symptoms of the patient. A genetic test can also be done to confirm the diagnosis. The LMNA gene mutation that causes Hutchinson-Gilford Progeria Syndrome can be detected through Next Generation Sequencing (NGS) Genetic Testing. […] The NGS Genetic Test for Hutchinson-Gilford Progeria Syndrome is a valuable tool for early diagnosis and management of the disease. It can help patients and their families understand the disease and plan for the future. […] Hutchinson-Gilford Progeria Syndrome is a rare genetic disorder that causes premature aging and a shortened lifespan. The disease is caused by a mutation in the LMNA gene, which can be detected through NGS Genetic Testing.
  • #30 Progeria – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/progeria/symptoms-causes/syc-20356038
    Progeria is usually found in infancy or early childhood. This often happens at regular checkups, when a baby first shows the distinctive signs of premature aging. […] If you notice changes in your child that could be symptoms of progeria, or you have any concerns about your child’s growth or development, make an appointment with your child’s health care provider. […] There’s no cure for progeria, but new treatments and research show some promise for managing symptoms and complications. […] A change in one gene causes progeria. This gene, known as lamin A (LMNA), makes a protein that’s needed to hold the center of a cell, called the nucleus, together. […] The changed gene that causes progeria is rarely passed down in families. In most cases, the rare gene change that causes progeria happens by chance.
  • #31 About Progeria
    https://www.genome.gov/Genetic-Disorders/Progeria
    Progeria is an extremely rare genetic disease of childhood characterized by dramatic, premature aging. […] A genetic test for Hutchinson-Gilford progeria syndrome, also called HGPS, is currently available. In the past, doctors had to base a diagnosis of progeria solely on physical symptoms, such as skin changes and a failure to gain weight, that were not fully apparent until a child’s first or second year of life. This genetic test now enables doctors to diagnose a child at a younger age and initiate treatment early in the disease process. […] This genetic test for Hutchinson-Gilford progeria syndrome also serves to reassure parents of affected children that their disorder stems from a sporadic genetic mutation and that therefore it is unlikely that any future offspring would have the condition.
  • #32 Mayo Clinic Health Library – Progeria | Swiss Medical Network
    https://www.swissmedical.net/en/healtcare-library/con-20257475
    Progeria is usually found in infancy or early childhood. This often happens at regular checkups, when a baby first shows the distinctive signs of premature aging. […] Health care providers may suspect progeria based on symptoms. A genetic test for changes in the LMNA gene can confirm the diagnosis of progeria. […] A thorough physical exam of your child includes measuring height and weight. […] Progeria is a very rare condition. Your health care provider may need to gather more information before deciding on the next steps in caring for your child. […] There’s no cure for progeria. But regular monitoring for heart and blood vessel disease may help with managing your child’s condition. […] During medical visits, your child’s weight and height are measured and put on a chart that shows average measurements of children who are your child’s age. Routine evaluations often include electrocardiograms and echocardiograms to check the heart, imaging tests, such as X-ray and MRI, and dental, vision and hearing exams. […] A genetic counselor can give you information about the risk of having other children with progeria.
  • #33 Progeria: Causes, Symptoms, and Treatment Options | ABC Medical Center
    https://centromedicoabc.com/en/padecimientos/progeria/
    It is necessary to see a specialist if your child has these progeria characteristics for correct diagnosis and treatment. […] Once your doctor analyzes your child’s symptoms and medical history, they will perform a physical examination and laboratory tests to determine cholesterol and triglyceride levels, as well as insulin resistance. […] They will also request stress tests to see if there are cardiac irregularities and genetic tests to detect abnormalities. […] Although there is no cure for progeria and no specific treatment, taking aspirin daily can protect against stroke or heart attack. […] Depending on your child’s symptoms, the doctor may recommend the use of statins to lower cholesterol, anticoagulants to prevent blood clots, and medications to help reduce blood pressure, headaches, and seizures. […] Likewise, they will prescribe a diet with high caloric content, physical and occupational therapy sessions, as well as regular dental check-ups and general check-ups to delay the evolution of the disease so that your child has a better quality of life.
  • #34 The first case report of a child with progeria syndrome in Oman | ESPE2023 | 61st Annual ESPE (ESPE 2023) | ESPE Abstracts
    https://abstracts.eurospe.org/hrp/0097/hrp0097p2-71
    Hutchison-Gilford progeria syndrome (HGPS) is a rare genetic disorder which is characterized by aging fast in affected individuals. […] The patient was evaluated by multidisciplinary team for the various problems. […] Genetic testing by (PCR) with western blot protein analysis can confirm the diagnosis. […] Multidiscipline workup, including ECG, echocardiogram, carotid duplex scanning, hip Xdash;rays and bone densitometry scans should be done annually. […] Till now, no cure has been found for this catastrophic disorder however Lonafarnib is recently approved by FDA as the as the first treatment of progeria.
  • #35 Progeria: MedlinePlus Medical EncyclopediaLock
    https://medlineplus.gov/ency/article/001657.htm
    Progeria is a rare genetic condition that produces rapid aging in children. […] Your health care provider will perform a physical exam and order laboratory tests. This may show: […] Genetic testing can detect changes in the gene (LMNA) that causes progeria. […] There is no specific treatment for progeria. Aspirin and statin medicines may be used to protect against a heart attack or stroke. […] Contact your provider if your child does not appear to be growing or developing normally.
  • #36 Who Is the Oldest Progeria Survivor? List, Symptoms
    https://www.medicinenet.com/who_is_the_oldest_progeria_survivor/article.htm
    The reason Tiffany Wedekind’s progeria remained undiagnosed for so long was that she never had any health issues other than her teeth falling out. […] Progeria is a rare, progressive disease caused by a single genetic mutation. This condition involves the gene LMNA (lamin A), which produces a protein known as progerin, which is responsible for maintaining the structural integrity of the cell’s nucleus. […] The condition is diagnosed based on signs and symptoms and a physical examination. […] Genetic testing can confirm LMNA gene mutations. […] Currently, there is no cure for progeria. […] To detect cardiovascular disease at an early stage, it is necessary to monitor the heart regularly. […] There are several treatment options available to relieve some signs and symptoms of progeria, including aspirin, statins, antihypertensives, heparin or warfarin, antiepileptic medications, physical and occupational therapy, and a nutritious diet. […] To treat progeria, more investigation or research is needed on gene mutations to uncover the cause of this disease and develop new treatments. […] Progeria is recognized at an early age, usually during regular checkups, when the symptoms of premature aging begin to appear in infants.
  • #37 Children living with progeria – MedCrave online
    https://medcraveonline.com/NCOAJ/children-living-with-progeria.html
    There is no cure for Progeria, at this time, but researchers are working on finding one. Treatments usually help to delay some of the disease’s symptoms includes: FTIs (farnesyltransferase inhibitors), is a kind of cancer drug, which may repair the damaged cells. […] Progeria is caused by a genetic mutation, which means an individual has inherited a mutated gene from parents. The mutation occurs in the LMNA gene, which is important for producing a protein that helps maintain the structural integrity of the nucleus in cells. […] The average lifespan for Progeria is 13 years, although some live into their 20s. […] Progeria does not affect mental development but intelligence tends to be average or above average.
  • #38 Progeria and processing-deficient Progeroid Laminopathies | Sentynl Therapeutics, Inc.
    https://www.zokinvy.com/hcp/understanding-progeria-and-pdpl
    Early diagnosis of Progeria and PDPL allows for earlier, targeted intervention. […] Once a diagnosis is confirmed, initiate Zokinvy immediately if the patient is 12 months of age or older and with a body surface area (BSA) of 0.39 m2 and above. […] Genetic testing to detect LMNA or ZMPSTE24 mutations is offered by labs. […] The Progeria Research Foundation offers a genetic testing program through laboratories certified by Certified Laboratory Improvement Amendments (CLIA) and in collaboration with the treating physician.
  • #39 Israel Just Made Its First Progeria Diagnosis – Patient Worthy
    https://patientworthy.com/2023/06/13/first-israeli-child-progeria-diagnosis/
    Israel recently diagnosed the first case of progeria within the country: a young girl who is just two months old. […] At Rambam Medical Center, located in Haifa, Israel, the parents discussed what might be happening with doctors. Dr. Hiba Zaaroura recommended genetic testing. Soon after, the family received the diagnosis: progeria. […] Through this communication, Dr. Zaaroura and her team will gain the necessary knowledge to provide the best care to this little girl. Over the coming years, the little girl will need to undergo frequently cardiac monitoring and gastroenterology care. […] Right now, the little girl is not old enough to begin lonafarnib treatment. Lonafarnib, given orally, is thought to delay the progression of progeria and to increase overall lifespan. She will be put on treatment as soon as she hits her first birthday.
  • #40 Common Front Against Progeria, the Aging Child Disease | CiMUS
    https://cimus.usc.gal/index.php/news/common-front-against-progeria-aging-child-disease
    Two of the biggest challenges faced by patients with this condition are the lack of or delay in proper diagnosis and treatment, due to limited research and funding in this field. […] The foundation is the only global organization dedicated to studying and researching this disease, with an average diagnosis time of four years. […] „In fact, it takes an average of four years to receive a diagnosis, and in 20% of cases, it takes ten years or more to reach an accurate diagnosis,” she adds. […] One of the major issues these patients face is the lack of adequate diagnosis and treatment, largely due to insufficient research. […] Progeria, also known as Hutchinson-Gilford syndrome, is an extremely rare genetic disorder caused by a single nucleotide mutation, leading to accelerated aging in children from the age of two.
  • #41 Common Front Against Progeria, the Aging Child Disease | CiMUS
    https://cimus.usc.gal/index.php/news/common-front-against-progeria-aging-child-disease
    Two of the biggest challenges faced by patients with this condition are the lack of or delay in proper diagnosis and treatment, due to limited research and funding in this field. […] The foundation is the only global organization dedicated to studying and researching this disease, with an average diagnosis time of four years. […] „In fact, it takes an average of four years to receive a diagnosis, and in 20% of cases, it takes ten years or more to reach an accurate diagnosis,” she adds. […] One of the major issues these patients face is the lack of adequate diagnosis and treatment, largely due to insufficient research. […] Progeria, also known as Hutchinson-Gilford syndrome, is an extremely rare genetic disorder caused by a single nucleotide mutation, leading to accelerated aging in children from the age of two.
  • #42 Progeria in Babies | American Pregnancy Association
    https://americanpregnancy.org/healthy-pregnancy/birth-defects/progeria/
    Hutchinson-Gilford Progeria Syndrome is commonly referred to as Progeria or HGPS. It is a genetic condition that occurs in 1 of every 4 to 8 million newborns and manifests itself physically in children as rapid aging. The most common type is known as Hutchinson-Gilford Progeria Syndrome. […] The disorder is not regularly tested for, as it is extremely rare, and there is no genetic link — when tested it is done through amniocentesis. […] Once diagnosed, children can achieve a fair quality of life with the right care. Worthwhile treatment would address the major physical issues associated with the disorder.
  • #43 Progeria 101 FAQ | The Progeria Research Foundation
    https://www.progeriaresearch.org/progeria-101faq/
    Because of the historic Progeria gene discovery, we have a definitive, scientific way to diagnose the children. This results in more accurate and earlier diagnoses so they can receive proper care. The Progeria Research Foundation has a Diagnostic Testing Program that looks at the specific genetic change, or mutation, in the Progeria gene that leads to HGPS. After an initial clinical evaluation (looking at the child’s appearance and medical records), a sample of the child’s blood is tested for Progeria. Genetic testing is also available at some genetic diagnostics facilities. Accompanying genetic counseling is always advised. […] The Progeria Research Foundation funds medical research aimed at developing treatments and the cure for Progeria. PRF also has its own Cell and Tissue Bank that provides the biological materials researchers need to conduct their experiments. Additionally, PRF has a Medical and Research Database a centralized collection of medical information from Progeria patients worldwide. The data are rigorously analyzed to help us understand more about Progeria and devise treatment recommendations.
  • #44 New Study: Defining the Progeria Phenome | Aging
    https://www.aging-us.com/news-room/New-Study-Defining-the-Progeria-Phenome
    In sum, we have defined what a premature aging disease is and developed tools to allow diagnostics of patients and disease population. […] In this study, we have utilized phenome explorations to define the phenotypes associated with progerias and to develop tools to diagnose patients and identify new progeroid syndromes. […] In conclusion, our study has provided tools to evaluate the likelihood of a syndrome or patient being progeroid. This is a considerable step forward in our understanding of what constitutes a premature aging disorder and how to diagnose them.
  • #45 New Study: Defining the Progeria Phenome | Aging
    https://www.aging-us.com/news-room/New-Study-Defining-the-Progeria-Phenome
    In sum, we have defined what a premature aging disease is and developed tools to allow diagnostics of patients and disease population. […] In this study, we have utilized phenome explorations to define the phenotypes associated with progerias and to develop tools to diagnose patients and identify new progeroid syndromes. […] In conclusion, our study has provided tools to evaluate the likelihood of a syndrome or patient being progeroid. This is a considerable step forward in our understanding of what constitutes a premature aging disorder and how to diagnose them.
  • #46 Common Front Against Progeria, the Aging Child Disease | CiMUS
    https://cimus.usc.gal/index.php/news/common-front-against-progeria-aging-child-disease
    Although significant advances have been made in genetic therapy for mouse models successfully reversing the mutation responsible, their application in humans remains unfeasible. For this reason, many current treatments focus on alleviating the primary symptoms of the disease. […] Currently, multiple research efforts including those led by CiMUS aim to evaluate new treatments that, when combined with lonafarnib, could further increase both life expectancy and quality of life for affected children.
  • #47 Progeria: Causes, Symptoms, Diagnosis, and Treatment
    https://www.medicoverhospitals.in/diseases/progeria/
    Diagnosis of progeria is primarily based on clinical evaluation and the observation of characteristic physical signs. Pediatricians often look for growth delays and typical physical features associated with progeria. […] Confirmatory diagnosis is achieved through genetic testing. A blood sample is analyzed to identify the LMNA gene mutation responsible for progeria. Early diagnosis is crucial for the timely management and treatment of the condition.
  • #48 Hutchinson-Gilford progeria | BMJ Case Reports
    https://casereports.bmj.com/content/16/9/e256203
    Knowledge of specific clinical features narrows the differential to test for specific mutations, thus bringing down the cost of genetic testing. […] A correct diagnosis holds prognostic value as well as the possibility of trial of farnesyl transferase inhibitors such as lonafarnib, which has shown improved mortality outcomes in these patients with an HR of 0.12. […] Early clinical constellation of findings that point towards the genetic diagnosis of Hutchinson-Gilford progeria includes sclerodermoid skin change, alopecia, cutaneous dyspigmentation, prominent veins and failure to thrive. […] Patients of Hutchinson-Gilford progeria should be screened for cardiac and metabolic comorbidities and kept under regular follow-up, as the most common cause of death is cardiovascular. […] Farnesyl transferase inhibitors may have a mortality benefit, and there is currently an ongoing trial in combination with everolimus (NCT02579044).
  • #49 Who Is the Oldest Progeria Survivor? List, Symptoms
    https://www.medicinenet.com/who_is_the_oldest_progeria_survivor/article.htm
    The reason Tiffany Wedekind’s progeria remained undiagnosed for so long was that she never had any health issues other than her teeth falling out. […] Progeria is a rare, progressive disease caused by a single genetic mutation. This condition involves the gene LMNA (lamin A), which produces a protein known as progerin, which is responsible for maintaining the structural integrity of the cell’s nucleus. […] The condition is diagnosed based on signs and symptoms and a physical examination. […] Genetic testing can confirm LMNA gene mutations. […] Currently, there is no cure for progeria. […] To detect cardiovascular disease at an early stage, it is necessary to monitor the heart regularly. […] There are several treatment options available to relieve some signs and symptoms of progeria, including aspirin, statins, antihypertensives, heparin or warfarin, antiepileptic medications, physical and occupational therapy, and a nutritious diet. […] To treat progeria, more investigation or research is needed on gene mutations to uncover the cause of this disease and develop new treatments. […] Progeria is recognized at an early age, usually during regular checkups, when the symptoms of premature aging begin to appear in infants.